ArriVent BioPharma, Inc. reports

Location
18 Campus Blvd., Suite 100, Newtown Square, PA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/14/2024, 08:03 AM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Nov 14, 2024 Sep 30, 2024
8-K Report | Data 8-K Nov 14, 2024 Nov 14, 2024
SC 13G Report SC 13G Nov 12, 2024
SC 13G Report Nov 12, 2024
SC 13G Report Nov 8, 2024
SC 13G Report Oct 24, 2024
SC 13G Report Oct 11, 2024
8-K Report | Data FORM 8-K Sep 9, 2024 Sep 9, 2024
10-Q Report | Data 10-Q Aug 14, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 14, 2024 Aug 14, 2024
8-K/A Report | Data 8-K/A Jul 9, 2024 May 16, 2024
8-K/A Report | Data FORM 8-K/A Jul 9, 2024 Apr 20, 2024
8-K Report | Data FORM 8-K Jun 5, 2024 Jun 4, 2024
8-K Report | Data FORM 8-K May 16, 2024 May 16, 2024
10-Q Report | Data 10-Q May 8, 2024 Mar 31, 2024
8-K Report | Data 8-K May 8, 2024 May 8, 2024
8-K Report | Data FORM 8-K Apr 22, 2024 Apr 20, 2024
10-K Report 10-K Mar 28, 2024 Dec 31, 2023
8-K Report | Data FORM 8-K Mar 28, 2024 Mar 28, 2024
SC 13G Report SCHEDULE 13G Feb 13, 2024
SC 13D Report SCHEDULE 13D Feb 5, 2024
8-K Report | Data FORM 8-K Jan 30, 2024 Jan 30, 2024